INS and metabolic dysfunction-associated steatotic liver disease: An insulin-resistant state, being a common driver in the development and progression of NAFLD, is associated with dysregulated glucose metabolism in the liver, muscle and adipocytes and increased lipolysis in the latter followed by free fatty acids release upregulation (8).